APA’s New Eating Disorder Guide; TMS Coils Compared; Take-Home Psilocybin?
— News and commentary from the psychiatry world
Kristen Monaco, Staff Writer, MedPage Today
February 1, 2023
A twin study found that avoidant restrictive food intake disorder (ARFID) — formerly dubbed selective eating disorder — has strong genetic factors. “The genetic component is higher than that of other eating disorders and on par with that of neuropsychiatric disorders such as autism and ADHD,” study author Lisa Dinkler, PhD, of the Karolinska Institutet in Stockholm, said in a statement. (JAMA Psychiatry)
In related news, the American Psychiatric Association (APA) released a new practice guideline for treating patients with eating disorders. (American Journal of Psychiatry)
Deep transcranial magnetic stimulation (TMS) targeting the medial prefrontal cortex with the H7 Coil for treating depression led to a similar response rate compared with targeting the lateral prefrontal cortex using the H1 Coil, a randomized trial found. (JCI Insight)
How common is postpartum psychosis? (NBC News)
Beta blockers were tied with a significantly lower risk of being charged with a violent crime, according to a study of 1.4 million Swedish individuals. (PLOS Medicine)
Highly processed food addiction? A recent University of Michigan poll of adults ages 50 and older found that 13% met the criteria for it.
Use of medical cannabis was associated with reductions in opioid intake for chronic pain patients on long-term opioid treatment, a cohort study from New York state found. (JAMA Network Open)
The first take-home trial of psilocybin in North America just kicked off in Canada for the treatment of post-traumatic stress disorder (PTSD), Apex Labs announced.
How much opioid-use disorder treatment is costing U.S. health systems. (Axios)
Substance use dropped across almost all categories among teens and young adults in the early part of 2020 — a trend that wasn’t consistent in older age groups. (JAMA Network Open)
Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.